We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Eli Lilly and Co | NYSE:LLY | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -15.91 | -2.10% | 740.00 | 745.00 | 730.34 | 743.10 | 4,593,881 | 01:00:00 |
From May 2019 to May 2024
By Michael Dabaie
Eli Lilly and Company (LLY) and Evidation Health expanded their collaboration with a multi-year agreement to provide Lilly with global access to Evidation's Andromeda data platform.
Lilly scientists and researchers will have access to Evidation's data platform to uncover new ways to measure patients' health by accessing consented data derived from smartphones, connected sensors and wearables.
Lilly didn't disclose the terms of the agreement.
With Andromeda, Lilly scientists can use Evidation-built algorithms to process raw data for use in clinical studies or to create their own predictive models, the company said.
Write to Michael Dabaie at michael.dabaie@wsj.com
(END) Dow Jones Newswires
December 14, 2018 07:33 ET (12:33 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
1 Year Eli Lilly Chart |
1 Month Eli Lilly Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
